This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Thyroid Cancer
  • /
  • Laser Ablation of Papillary Thyroid Microcarcinoma
Clinical trial

Laser Ablation of Papillary Thyroid Microcarcinoma

Read time: 1 mins
Last updated:12th Apr 2021
Status: Recruiting
Identifier: NCT04623801
Laser Ablation of Papillary Thyroid Microcarcinoma

The purpose of this study is to explore whether percutaneous laser ablation (PLA) is a safe and effective alternative to removing papillary thyroid microcarcinoma (PTMC) with surgery.

Study Type: Interventional (Clinical Trial)
Estimated Enrollment: 10 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Pilot Study to Evaluate the Safety and Efficacy of Percutaneous Laser Ablation of Thyroid Papillary Microcarcinoma
Actual Study Start Date: October 19, 2020
Estimated Primary Completion Date: October 2022
Estimated Study Completion Date: October 2022

- Experimental: Participants with papillary microcarcinoma (PTMC)

Category Value
Study type(s) Interventional
Estimated enrolment 10
Actual Study start date 19 October 2020
Estimated Study Completion Date 01 October 2022

View full details